Showing results (281-290 of 9,399) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|November 12, 2002
Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemiaPatrizia Blardi, Renato Urso, Arianna De Lalla, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxelJosephia R Muindi, Yibing Peng, Douglas M Potter, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Population pharmacokinetics of tacrolimus in adult kidney transplant recipientsChristine E Staatz, Charlene Willis, Paul J Taylor, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Benzodiazepines and the risk of urinary incontinence in frail older persons living in the communityFrancesco Landi, Matteo Cesari, Andrea Russo, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Diadenosine pentaphosphate vasodilates the forearm vascular bed: inhibition by theophylline and augmentation by dipyridamoleEgidia E M van Ginneken, Gerard A Rongen, Frans G m Russel, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis CLaurent Becquemont, Olivier Chazouilleres, Lawrence Serfaty, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosingMarc P Maillard, Grégoire Würzner, Jürg Nussberger, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemiaYasmina Chodjania, Pierre-Louis Tharaux, Isabelle Ragueneau, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisolHideki Ushiama, Hirotoshi Echizen, Shinobu Nachi, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black AmericansAndrea Gaedigk, L DiAnne Bradford, Kenda A Marcucci, et al.
Pageof 940